These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 16107144)

  • 21. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
    Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
    J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
    Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
    J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
    Kellenberger E; Foata N; Rognan D
    J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening.
    de Graaf C; Foata N; Engkvist O; Rognan D
    Proteins; 2008 May; 71(2):599-620. PubMed ID: 17972285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions.
    Strömbergsson H; Prusis P; Midelfart H; Lapinsh M; Wikberg JE; Komorowski J
    Proteins; 2006 Apr; 63(1):24-34. PubMed ID: 16435365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homology modeling and docking evaluation of aminergic G protein-coupled receptors.
    McRobb FM; Capuano B; Crosby IT; Chalmers DK; Yuriev E
    J Chem Inf Model; 2010 Apr; 50(4):626-37. PubMed ID: 20187660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-binding modes in cationic biogenic amine receptors.
    Ishiguro M
    Chembiochem; 2004 Sep; 5(9):1210-9. PubMed ID: 15368572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel serotonin 2C receptor ligands by sequential virtual screening.
    Ahmed A; Choo H; Cho YS; Park WK; Pae AN
    Bioorg Med Chem; 2009 Jul; 17(13):4559-68. PubMed ID: 19464901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
    Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
    ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual screening using protein-ligand docking: avoiding artificial enrichment.
    Verdonk ML; Berdini V; Hartshorn MJ; Mooij WT; Murray CW; Taylor RD; Watson P
    J Chem Inf Comput Sci; 2004; 44(3):793-806. PubMed ID: 15154744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autocorrelation of molecular electrostatic potential surface properties combined with partial least squares analysis as new strategy for the prediction of the activity of human A(3) adenosine receptor antagonists.
    Moro S; Bacilieri M; Cacciari B; Spalluto G
    J Med Chem; 2005 Sep; 48(18):5698-704. PubMed ID: 16134938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SeleX-CS: a new consensus scoring algorithm for hit discovery and lead optimization.
    Bar-Haim S; Aharon A; Ben-Moshe T; Marantz Y; Senderowitz H
    J Chem Inf Model; 2009 Mar; 49(3):623-33. PubMed ID: 19231809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple active site corrections for docking and virtual screening.
    Vigers GP; Rizzi JP
    J Med Chem; 2004 Jan; 47(1):80-9. PubMed ID: 14695822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
    J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of automated in silico ligand docking of amino acid ligands to Family C G-protein coupled receptors.
    Wang M; Hampson DR
    Bioorg Med Chem; 2006 Mar; 14(6):2032-9. PubMed ID: 16297630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application.
    Kratochwil NA; Malherbe P; Lindemann L; Ebeling M; Hoener MC; Mühlemann A; Porter RH; Stahl M; Gerber PR
    J Chem Inf Model; 2005; 45(5):1324-36. PubMed ID: 16180909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.
    Cavasotto CN; Orry AJ; Abagyan RA
    Proteins; 2003 May; 51(3):423-33. PubMed ID: 12696053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators.
    Yang JM; Shen TW
    Proteins; 2005 May; 59(2):205-20. PubMed ID: 15726586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.